T-cell Acute Lymphoblastic Lymphoma
8 clinical trials · Condition
◉ Watch T-cell Acute Lymphoblastic Lymphoma
| Record | Firm | Date |
|---|---|---|
| Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells (NCT03690011) | Baylor College of Medicine | 2021-08-02 |
| Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances (NCT04934774) | iCell Gene Therapeutics | 2020-12-01 |
| Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell Malignancies (NCT05127135) | Fundamenta Therapeutics, Ltd. | 2020-01-22 |
| Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen (NCT03081910) | Baylor College of Medicine | 2017-11-01 |
Track T-cell Acute Lymphoblastic Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.